| Tertiary lymphoid structures improve immunotherapy and survival in melanoma R Cabrita, M Lauss, A Sanna, M Donia, M Skaarup Larsen, S Mitra, ... Nature 577 (7791), 561-565, 2020 | 1879 | 2020 |
| A molecular taxonomy for urothelial carcinoma G Sjödahl, M Lauss, K Lövgren, G Chebil, S Gudjonsson, S Veerla, ... Clinical cancer research 18 (12), 3377-3386, 2012 | 977 | 2012 |
| Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma M Lauss, M Donia, K Harbst, R Andersen, S Mitra, F Rosengren, M Salim, ... Nature communications 8 (1), 1738, 2017 | 414 | 2017 |
| Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma D Lindgren, G Sjödahl, M Lauss, J Staaf, G Chebil, K Lövgren, ... PloS one 7 (6), e38863, 2012 | 231 | 2012 |
| Toward a molecular pathologic classification of urothelial carcinoma G Sjödahl, K Lövgren, M Lauss, O Patschan, S Gudjonsson, G Chebil, ... The American journal of pathology 183 (3), 681-691, 2013 | 213 | 2013 |
| Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ... Oncotarget 6 (14), 12297, 2015 | 200 | 2015 |
| NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics H Cirenajwis, M Lauss, H Ekedahl, T Törngren, A Kvist, LH Saal, H Olsson, ... Molecular oncology 11 (4), 438-451, 2017 | 155 | 2017 |
| A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma O Patschan, G Sjödahl, G Chebil, K Lövgren, M Lauss, S Gudjonsson, ... European urology 68 (5), 824-832, 2015 | 155 | 2015 |
| Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors G Sjödahl, K Lövgren, M Lauss, G Chebil, O Patschan, S Gudjonsson, ... Urologic Oncology: Seminars and Original Investigations 32 (6), 791-797, 2014 | 149 | 2014 |
| A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1 G Sjödahl, M Lauss, S Gudjonsson, F Liedberg, C Halldén, G Chebil, ... PloS one 6 (4), e18583, 2011 | 149 | 2011 |
| Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker I Johansson, C Nilsson, P Berglund, M Lauss, M Ringnér, H Olsson, ... Breast Cancer Research 14, 1-15, 2012 | 146 | 2012 |
| Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma K Harbst, M Lauss, H Cirenajwis, K Isaksson, F Rosengren, T Törngren, ... Cancer research 76 (16), 4765-4774, 2016 | 137 | 2016 |
| Molecular profiling reveals low-and high-grade forms of primary melanoma K Harbst, J Staaf, M Lauss, A Karlsson, A Måsbäck, I Johansson, ... Clinical cancer research 18 (15), 4026-4036, 2012 | 121 | 2012 |
| Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome A Karlsson, M Jönsson, M Lauss, H Brunnström, P Jönsson, Å Borg, ... Clinical Cancer Research 20 (23), 6127-6140, 2014 | 108 | 2014 |
| Characterization of the drugged human genome M Lauss, A Kriegner, K Vierlinger, C Noehammer Pharmacogenomics 8 (8), 1063-1073, 2007 | 99 | 2007 |
| Escape from nonsense-mediated decay associates with anti-tumor immunogenicity K Litchfield, JL Reading, EL Lim, H Xu, P Liu, M Al-Bakir, YNS Wong, ... Nature communications 11 (1), 3800, 2020 | 96 | 2020 |
| An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells K Holm, J Staaf, M Lauss, M Aine, D Lindgren, PO Bendahl, ... Breast Cancer Research 18, 1-20, 2016 | 91 | 2016 |
| Efficient arsenic metabolism—the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT KS Engström, MB Hossain, M Lauss, S Ahmed, R Raqib, M Vahter, ... PloS one 8 (1), e53732, 2013 | 87 | 2013 |
| B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? M Lauss, M Donia, IM Svane, G Jönsson Clinical cancer research 28 (9), 1751-1758, 2022 | 85 | 2022 |
| The X-linked DDX3X RNA helicase dictates translation reprogramming and metastasis in melanoma B Phung, M Cieśla, A Sanna, N Guzzi, G Beneventi, PCT Ngoc, M Lauss, ... Cell reports 27 (12), 3573-3586. e7, 2019 | 81 | 2019 |
Göran JönssonProfessor, Dept. of Oncology, Clinical Sciences, Lund University, SwedenZweryfikowany adres z med.lu.se
